The IBD&me Randomized Controlled Trial

Cedars-Sinai Medical Center logo

Cedars-Sinai Medical Center

Status

Completed

Conditions

Inflammatory Bowel Diseases

Treatments

Other: Standardized educational material
Other: Online decision aid called IBD&me

Study type

Interventional

Funder types

Other

Identifiers

NCT03695783
37998665

Details and patient eligibility

About

Navigating the risk-benefit profiles of the various biologic options approved for inflammatory bowel disease (IBD) can be challenging for patients who are considering biologic therapies as a treatment option. Thus, there is a need for simple and efficient tools that elicit individual preferences and support the patient-provider interaction. The principal objective of this study is to assess the impact of an online decision aid called IBD&me on patient perceptions of shared-decision making as compared to a standardized education arm.

Full description

Context: Navigating the risk-benefit profiles of the various biologic options approved for inflammatory bowel disease (IBD) can be challenging for patients who are considering biologic therapies as a treatment option. Thus, there is a need for simple and efficient tools that elicit individual preferences and support the patient-provider interaction. Objective: The principal objective of this study is to assess the impact of an online decision aid called IBD&me on patient perceptions of shared-decision making as compared to a standardized education arm. Hypothesis: IBD&me, through optimizing shared-decision making (SDM) and improving the patient-provider interaction, will provide incremental benefits beyond those provided by high-quality educational material without an SDM tool. Design: Pragmatic multicenter randomized controlled trial in IBD outpatient care Intervention: IBD&me is an online, freely available tool that allows patients to explore decision-making around biologic therapies for IBD at their own pace Control arm: Standardized, high-quality educational material from the Crohn's & Colitis Foundation

Enrollment

152 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Have ulcerative colitis (UC), Crohn's disease (CD), indeterminate colitis, or inflammatory bowel disease unclassified (IBD-U)
  • Have experienced IBD related symptoms in the 30 days before screening
  • Considering discussing biologic therapies for controlling his or her IBD at the next clinic visit
  • Have an IBD-related visit scheduled at least 7 days and no later than 3 months following screening

Exclusion criteria

  • Does not speak English
  • Does not have access to the Internet

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

152 participants in 2 patient groups

Online decision aid called IBD&me
Experimental group
Description:
IBD&me is an online, freely available tool that allows patients to explore decision-making around biologic therapies for IBD at their own pace. It includes an educational component and an interactive exercise with a series of ratings tasks that generates a personalized preferences report for patients to share and discuss with their physician.
Treatment:
Other: Online decision aid called IBD&me
Standardized educational material
Active Comparator group
Description:
PDF file corresponding to the CCFA's online resource on biologic therapies, which is a well-researched and clearly presented overview of IBD biologic therapies, but without an active shared-decision making component.
Treatment:
Other: Standardized educational material

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems